14-069-937

CD69 Monoclonal Antibody (FN50), eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 14-069-937-Each-of-1 In Stock ₹ 1,22,108.00

14-069-937 - Each of 1

₹ 1,22,108.00

In Stock

Quantity

1

Base Price: ₹ 1,22,108.00

GST (18%): ₹ 21,979.44

Total Price: ₹ 1,44,087.44

Antigen

CD69

Classification

Monoclonal

Concentration

0.5 mg/mL

Formulation

PBS with 0.09% sodium azide; pH 7.2

Gene Accession No.

Q07108

Gene Symbols

CD69

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

969

Content And Storage

4° C

Form

Liquid

Applications

Flow Cytometry, Immunohistochemistry

Clone

FN50

Conjugate

Unconjugated

Gene

CD69

Gene Alias

5830438K24Rik; Activation inducer molecule; activation inducer molecule (AIM/CD69); AI452015; AIM; BL-AC/P26; CD69; CD69 antigen; CD69 antigen (p60, early T-cell activation antigen); CD69 molecule; CLEC2C; C-type lectin domain family 2 member C; C-type lectin domain family 2, member C; EA1; early activation antigen CD69; early lymphocyte activation antigen; early T-cell activation antigen p60; GP32/28; leukocyte surface antigen Leu-23; MLR-3; VEA; Very Early Activation Antigen

Host Species

Mouse

Quantity

2 mg

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1 κ

Related Products

Img

Invitrogen

50-116-48

--

Img

Invitrogen

14-207-337

--

Img

Invitrogen

50-124-56

--

Img

Invitrogen

25-086-941

--

Img

Invitrogen

14-066-937

--

Img

Invitrogen

50-118-21

--

Img

Invitrogen

50-124-71

--

Img

Invitrogen

50-113-7032

--

Description

  • Description: The FN50 monoclonal antibody reacts with human CD69, also known as very early activation antigen (VEA)
  • CD69 is approximately 30 kDa and is expressed on the cell-surface as a disulfide-linked dimer
  • CD69 is rapidly upregulated upon activation and expressed on lymphocytes, monocytes and platelets
  • Applications Reported: The FN50 antibody has been reported for use in flow cytometric analysis and immunohistochemical staining
  • Applications Tested: The FN50 antibody has been tested by flow cytometric analysis of resting and 6-hour TPA-activated human normal human peripheral blood cells
  • This can be used at less than or equal to 0.5 μg per test
  • A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
  • Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
  • It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest
  • Purity: Greater than 90%, as determined by SDS-PAGE
  • Aggregation: Less than 10%, as determined by HPLC
  • Filtration: 0.2 μm post-manufacturing filtered
  • CD69 (AIM, Active Inducer Molecule) is a gp28/34 disulfide bonded homodimer with a molecular weight of 60 kDa under non-reducing conditions
  • CD69 contains one or two N linked oligosacaride and the molecule is present on activated platelets
  • In normal peripheral blood a variable percentage of cells express the CD69 antigen, and it is involved in lymphocyte signal transduction
  • Expression CD69 is induced upon activation of T lymphocytes, and may play a role in proliferation
  • Furthermore, the protein may act to transmit signals in natural killer cells and platelets
  • Alternative splicing results in multiple transcript variants of CD69
  • Diseases associated with CD69 dysfunction include coccidiodomycosis and asthma.